Inactive Instrument

Vivione Biosciences Inc

Investment Management & Fund Operators

PACEpartners Inc. will Change its Name to Vivione Biosciences Inc

July 23, 2013 at 09:30 am IST

Effective July 23, 2013, PACEpartners Inc. will change its name to Vivione Biosciences Inc.

Latest news about Vivione Biosciences Inc

Vivione Biosciences Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2018	28/18/28	CI
Vivione Biosciences Inc. Auditor Raises 'Going Concern' Doubt	04/18/04	CI
Vivione Biosciences Inc. Auditor Raises 'Going Concern' Doubt	03/17/03	CI
Vivione Biosciences Inc. Auditor Raises 'Going Concern' Doubt	29/16/29	CI
Vivione Biosciences Inc. Announces Resignation of Lal Narang from the Board of Directors	11/15/11	CI
Vivione Biosciences Inc. Announces Management Changes	02/15/02	CI
Vivione Biosciences Inc. Primary Exchange Listing will Change to TSX Venture Exchange - Nex from TSX Venture Exchange	02/15/02	CI
Vivione Biosciences Inc. announced that it has received $1 million in funding from Montalcino Holdings I, LLC	02/15/02	CI
Vivione Biosciences Inc. announced that it expects to receive $2.5 million in funding from Montalcino Holdings I, LLC.	15/15/15	CI
Vivione Biosciences Seeks Acquisitions	10/15/10	CI
Vivione Biosciences Enters into Loan Agreement with Mr. Glenn Smith, Director	06/15/06	CI
Vivione Biosciences Inc. Announces Resignation of Justin Springfield as Senior Vice President of Sales and Marketing	06/15/06	CI
Vivione Biosciences Finalizes Agreement with University of Rochester for Exclusive Worldwide Rights to Novel Infectious Disease-Related Biomarker	13/15/13	CI
Vivione Biosciences Inc. Announces A Research Collaboration with Northwestern University, Feinberg School of Medicine	11/15/11	CI
Vivione Biosciences Inc. Auditor Raises 'Going Concern' Doubt	30/15/30	CI
Vivione Biosciences Announces Successful Field Deployment of RAPID-B with Greene’s Energy Group, LLC	25/15/25	CI
Vivione Biosciences Announces Preferred Vendor Arrangement with Ely and Associates	17/15/17	CI
Vivione Biosciences Inc. announced that it expects to receive CAD 10 million in funding.	28/15/28	CI
Vivione Biosciences Announces Successful Completion of its Early-Stage Pilot Study at the Cleveland Clinic	16/14/16	CI
Vivione Biosciences Announces Termination of Ted Moskal as President of Company and Vivione Biosciences, LLC	27/14/27	CI
Vivione Biosciences Inc. to Introduce Justin Springfield as Senior Vice President of Sales & Marketing	10/14/10	CI
Vivione Biosciences Inc. Signs Strategic Alliance Agreement with Institute for Environmental Health, Inc	08/14/08	CI
Vivione Biosciences Inc. announced that it has received CAD 0.22 million in funding.	20/14/20	CI
Vivione Biosciences Inc. Forms Strategic Alliance with AriBio, Inc	12/14/12	CI
Vivione Biosciences Inc. Announces Management Appointments	29/14/29	CI

Vivione Biosciences Inc. is a technology and life sciences company. The Company is focused on rapid bacterial detection. The Company has developed a diagnostic system called RAPID-B, which tests bacteria in critical environments and provides quantitative results in approximately seven hours or less. Its RAPID-B is an integrated microbiology/infectious disease diagnostic system. Its primary targeting is accomplished with custom, optimized immuno-based reagents that are designed to target the cell surface of target bacteria without cross-reactivity to similar non-target bacteria. Its RAPID-B system has applications in various markets, including Hospitals, Universities and Clinics; testing system for bacterial detection and antimicrobial susceptibility profiles for bacterial infection in normally sterile body fluids, such as blood and urine, and detecting the presence of bacteria in blood and urine samples within minute's and days.

Sector

Investment Management & Fund Operators

More about the company

Sector Venture Capital

	1st Jan change	Capi.
HERCULES CAPITAL, INC.	+16.44%	310.4Cr
UMBRA COMPANIES INC.	+12.82%	176.95Cr
OCTOPUS TITAN VCT PLC	-11.54%	121.12Cr
MOLTEN VENTURES PLC	+17.80%	79Cr
CION INVESTMENT CORPORATION	+9.81%	67Cr
VERUSA HOLDING	+28.17%	57Cr
OCTOPUS APOLLO VCT PLC	-4.17%	51Cr
WOORI TECHNOLOGY INVESTMENT CO., LTD	+34.47%	50Cr
BITCOIN GROUP SE	+80.62%	34Cr

Venture Capital

Vivione Biosciences Inc

Equities

Investment Management & Fund Operators

PACEpartners Inc. will Change its Name to Vivione Biosciences Inc

Latest news about Vivione Biosciences Inc

Chart Vivione Biosciences Inc

Company Profile

Sector Venture Capital